Bayesian Capital Management’s Abbott ABT Stock Holding History

Bayesian Capital Management’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,100	Closed	-$764K	–	138
2025 Q4	$764K	Buy	+6,100	New	+$777K	1.75%	13
2024 Q2	–	Sell	-14,600	Closed	-$1.66M	–	685
2024 Q1	$1.66M	Sell	14,600 -40,944	-74%	-$4.69M	0.16%	184
2023 Q4	$6.11M	Buy	55,544 +49,944	+892%	+$4.99M	0.65%	22
2023 Q3	$542K	Sell	5,600 -27,900	-83%	-$2.93M	0.06%	355
2023 Q2	$3.65M	Buy	+33,500	New	+$3.57M	0.39%	44
2022 Q4	–	Sell	-3,000	Closed	-$290K	–	746
2022 Q3	$290K	Buy	+3,000	New	+$320K	0.06%	420
2021 Q4	–	Sell	-18,609	Closed	-$2.2M	–	364
2021 Q3	$2.2M	Buy	+18,609	New	+$2.29M	0.64%	29
2021 Q1	–	Sell	-3,700	Closed	-$405K	–	517
2020 Q4	$405K	Sell	3,700 -10,100	-73%	-$1.1M	0.11%	248
2020 Q3	$1.5M	Buy	+13,800	New	+$1.4M	0.37%	65
2019 Q1	–	Sell	-7,173	Closed	-$519K	–	530
2018 Q4	$519K	Buy	+7,173	New	+$504K	0.11%	278
2018 Q3	–	Sell	-10,839	Closed	-$661K	–	608
2018 Q2	$661K	Sell	10,839 -43,500	-80%	-$2.64M	0.15%	197
2018 Q1	$3.26M	Buy	+54,339	New	+$3.27M	0.83%	4

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bayesian Capital Management's ABT Position: Q1 2026 in Review

Bayesian Capital Management sold out of Abbott (ABT) in Q1 2026, closing a stake of 6,100 shares — an estimated $764K sold.

Bayesian Capital Management first reported a position in ABT in Q1 2018 and held it in 12 quarters. The position peaked at $6.11M in Q4 2023. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Bayesian Capital Management reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Bayesian Capital Management sold 6,100 Abbott shares in Q1 2026, an estimated $764K.
Bayesian Capital Management first reported a position in Abbott in Q1 2018 and held it in 12 quarters.
Bayesian Capital Management's Abbott position peaked at $6.11M in Q4 2023.
3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.